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Ataxia-telangiectasia Mutated (ATM), mutated in the
human disorder ataxia-telangiectasia, is rapidly acti-
vated by DNA double strand breaks. The mechanism of
activation remains unresolved, and it is uncertain
whether autophosphorylation contributes to activation.
We describe an in vitro immunoprecipitation system
demonstrating activation of ATM kinase from unirradi-
ated extracts by preincubation with ATP. Activation is
both time- and ATP concentration-dependent, other nu-
cleotides fail to activate ATM, and DNA is not required.
ATP activation is specific for ATM since it is not ob-
served with kinase-dead ATM, it requires Mn2, and it is
inhibited by wortmannin. Exposure of activated ATM to
phosphatase abrogates activity, and repeat cycles of
ATP and phosphatase treatment reveal a requirement
for autophosphorylation in the activation process. Phos-
phopeptide mapping revealed similarities between the
patterns of autophosphorylation for irradiated and
ATP-treated ATM. Caffeine inhibited ATM kinase activ-
ity for substrates but did not interfere with ATM auto-
phosphorylation. ATP failed to activate either A-T and
rad3-related protein (ATR) or DNA-dependent protein
kinase under these conditions, supporting the specific-
ity for ATM. These data demonstrate that ATP can spe-
cifically induce activation of ATM by a mechanism in-
volving autophosphorylation. The relationship of this
activation to DNA damage activation remains unclear
but represents a useful model for understanding in vivo
activation.
Neurodegeneration, immunodeficiency, genome instability,
and cancer susceptibility represent the major hallmarks of the
human genetic disorder ataxia-telangiectasia (A-T)1 (1, 2). Ex-
treme sensitivity to radiation in patients undergoing radiother-
apy for cancer and in cells in culture are also characteristic of
this disease (3–5). The exact basis of the radiosensitivity in A-T
cells remains unknown but appears to be related to the failure
to repair residual chromosomal breaks (6, 7) or activation of the
structural maintenance of chromosomes (SMC1) protein in re-
sponse to DNA damage, which is ATM-dependent and impli-
cated in modulating radiosensitivity (8, 9). In A-T cells, faulty
DNA damage recognition is also accompanied by defective cell
cycle checkpoint activation, which is likely to contribute to the
genetic instability and cancer susceptibility in this syndrome
(10, 11).
The gene defective in A-T, ATM (A-T mutated), encodes a
protein that is a member of the phosphatidylinositol 3-kinase
(PI3-kinase) family (12). This group includes the catalytic sub-
unit of DNA-dependent protein kinase (DNA-PKcs), A-T and
rad3-related protein (ATR), and proteins in different organisms
responsible for DNA damage recognition and cell cycle control
(13). Although there is some evidence for regulation of ATM at
the transcriptional and translational levels (14), it is primarily
activated as a pre-existing protein by ionizing radiation and
other agents that give rise to double strand breaks in DNA,
suggesting that post-translational modification may be impor-
tant in its activation (15–17). Changes in abundance of ATM
protein in response to radiation have not been observed (18).
Once activated, ATM phosphorylates a host of substrates, pri-
marily involved in recognizing DNA damage or signaling this
damage to cell cycle checkpoints (19), but there is also evidence
for non-DNA damage activation (20). Among the ATM sub-
strates involved in DNA damage recognition are Nbs1, defec-
tive in the Nijmegen breakage syndrome (21–23), BRCA1 (24,
25), Rad51 (26), and BLM, defective in Bloom’s syndrome (27).
ATM also plays a central role in the activation of cell check-
points in response to radiation damage (10, 11). It is of some
interest that this regulation occurs at multiple levels for a
single checkpoint. In the case of the G1/S checkpoint, activated
ATM phosphorylates p53 on serine 15 (15–17), it also phospho-
rylates and activates Chk2 to in turn phosphorylate p53 on
serine 20 (28), which may contribute to its stabilization at least
in some cell types, and by phosphorylating mdm2 on serine 395
(29), it further ensures stabilization and activation of p53 to
induce p21/WAF1 and the G1/S checkpoint (30, 31). ATM phos-
phorylates Chk2, Nbs1, SMC1, and BRCA1 to achieve activa-
tion of the S phase checkpoint in parallel pathways (8, 9, 32).
Finally, Chk2 and BRCA1 are also substrates for ATM in the
G2/M checkpoint (33).
Although multiple substrates and pathways controlled by
ATM have been identified, it remains unclear as to how double
strand breaks in DNA activate its kinase activity. In the case of
the related PI3-kinase, DNA-PKcs, it is recruited to DNA
strand breaks and activated by the Ku70/Ku80 heterodimer
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(34). Intriguingly, inositol hexakisphosphate stimulates DNA-
PK-dependent non-homologous DNA end joining in vitro, and
this appears to be achieved by specific interaction with Ku70/
Ku80 (35). Another member of the PI3-kinase family mTOR is
altered in its activity by small molecules, acting as a sensor of
ATP concentration (36). Protein kinase activity can also be
regulated by autophosphorylation, which has been observed
with DNA damage signaling PI3-kinases (37). However, only
DNA-PK autophosphorylation was demonstrated to have an
effect on the functional activity of the enzyme in a DNA-de-
pendent manner (38). Autophosphorylation causes inactivation
of DNA-PK kinase activity and disruption of the DNA-PKcs-Ku
complex. Subsequently, it was shown that phosphatase treat-
ment activated DNA-PK (39). Autophosphorylation has also
been observed with ATM immunoprecipitated from irradiated
control cells and with ATM expressed in baculovirus (25, 40),
and there is evidence using 32P-labeling in vivo to support this
(23, 41), but its importance to ATM function has not been
addressed. The putative autophosphorylation sites on ATM
were suggested based on consensus motifs expected to be rec-
ognized by ATM in oriented peptide libraries (42). These in-
clude Ser-2941, Ser-1635, and Ser-440, but phosphorylation of
these sites in vivo has not been reported. To investigate the
activation of ATM and the possible involvement of autophos-
phorylation in this process, we have established an in vitro
system involving immunoprecipitation of ATM and activation
by ATP.
EXPERIMENTAL PROCEDURES
Materials and Reagents—Cell culture medium RPMI 1640 was from
Invitrogen. Fetal bovine serum was from JRH Biosciences. Microcystin
LR was from Biomol Research Laboaratories, Inc. (Sapphire Bio-
science). -Protein phosphatase (-PPase) was from New England Bio-
labs. ATP, ADP, AMP, NADP, 5-adenylylimidodiphosphate (AMP-
PNP), GTP, and okadaic acid were from Sigma. Wortmannin and
caffeine were from Fluka Chemie AG. Protein G-Sepharose 4 fast flow,
protein A-Sepharose CL-4B, and Redivue [-32P]ATP (specific activity
3000 Ci/Mmol) were from Amersham Biosciences. Western Lightning
chemiluminescence reagent was from PerkinElmer Life Sciences. Anti-
mouse and anti-rabbit antibodies conjugated with peroxidase were from
Silenus/Chemicon Australia. For ATM Western blotting, ATM 2C1
monoclonal antibody (GeneTex) was used. For ATR Western blotting
and immunoprecipitations, ATR PA1–450 antibody (Affinity Biore-
agents) was employed. Western blotting and immunoprecipitations for
DNA-PK were performed with Ab-2 monoclonal antibody (Oncogene
Research Products). All other reagents were from standard suppliers or
as indicated in the text.
Cell Lines and Irradiation—Lymphoblastoid cell lines established
from normal (C3ABR) and A-T patients (L3 and AT1ABR) were used.
We acknowledge Yosef Shiloh, Tel Aviv, Israel for the L3 cell line that
fails to produce ATM protein due to a homozygous truncation mutation
(C103T). AT1ABR is an A-T cell line homozygous for the 7636del9
mutation that produces near full-length ATM protein that is kinase-
dead (25). The Lymphoblastoid cell lines were cultured in RPMI 1640
medium with 10% fetal calf serum, 100 units/ml penicillin (Invitrogen),
and 100 units/ml streptomycin (Invitrogen). All irradiations were per-
formed at room temperature using an IBL437C irradiator (2.4 Gy/min,
Compagnie ORIS Industrie).
Antibody Production—Construction of GST fusion proteins contain-
ing fragments of ATM protein was described previously (17). GST-
ATM2 fusion protein (ATM amino acids 250–522) was expressed ac-
cording to standard protocol (43). Full-length GST-ATM2 was isolated
by preparative SDS-PAGE, eluted from gel slices, and used for sheep
immunization according to standard protocols. Antibodies were purified
from collected sheep sera by two consecutive affinity chromatography
steps. GST-Affi-Gel 15 and GST-ATM2-Affi-Gel 15 affinity columns
were synthesized according to the manufacturer’s instructions (Bio-
Rad). Firstly, serum diluted 1/10 in phosphate-buffered saline was
applied to a GST-Affi-Gel 15 column to deplete it from anti-GST anti-
bodies. Secondly, serum was passed through a GST-ATM2-Affi-Gel 15
column, and ATM-specific antibodies were eluted, dialyzed against
phosphate-buffered saline containing 0.05% sodium azide, and concen-
trated by ultrafiltration on Ultrafree-4 BioMax 30K centrifugal filter
(Millipore). Affinity-purified antibodies were used in all subsequent
immunoprecipitations and kinase assays.
Immune Complex Protein Kinase Assays—Cells were collected by
diluting with an equal volume of ice-cold phosphate-buffered saline
containing 1 mM Na3VO4 and 1 mM NaF followed by centrifugation.
After a brief wash with ice-cold phosphate-buffered saline, cells were
lysed immediately for use in immune complex kinase assays. ATM,
ATR, and DNA-PK kinase assays were performed as described (16, 44,
45) with modifications. 0.2% Tween 20 lysis buffer was modified by
addition of 1 mM Na3VO4, 1 mM NaF, 10 mM Na2MoO4, 20 mM -glyc-
erophosphate, 5 M microcystin-LR, 5 nM okadaic acid, 5 g/ml each of
aprotinin, leupeptin, and pepstatin, 1 mM phenylmethylsulfonyl fluo-
ride, and 1 mM dithiothreitol. Cells were lysed by rotating for 45 min at
4 °C followed by centrifugation at 13,000  g for 10 min. Cell lysates
were precleared by constant mixing for 1 h with protein A/G-Sepharose.
1 mg of precleared lysate was used for immunoprecipitation with ATM,
ATR, or DNA-PK antibodies (see above) overnight with constant mix-
ing. Immune complexes were absorbed onto protein G-Sepharose and
washed. After two washes with ice-cold lysis buffer, one wash with high
salt buffer (lysis buffer with 0.5 M NaCl), and two washes with basic
kinase buffer, immunocomplexes were subjected to procedures outlined
below or used directly in kinase reactions. All washing buffers con-
tained 1 mM Na3VaO4, 1 mM NaF, and 1 mM phenylmethylsulfonyl
fluoride. The immunoprecipitates were resuspended in 30 l of kinase
buffer as described (44), and kinase reaction was carried out for 30 min
at 30 °C either for autophosphorylation or for substrate phosphoryla-
tion of 1 g of GST-p53 1–44. Linear reaction conditions were established
for ATM kinase assays. The reaction was stopped by addition of 5 l of
6 SDS gel loading buffer. The reaction products were separated by
SDS-PAGE. A biphasic gel system similar to one described by Ziv et al.
(46) was used. The top part of the separating gel (5%) was used for
immunoblot analysis of ATM, ATR, or DNA-PK to give an accurate
estimation of the amount of kinase present in the reaction. The bottom
part of the gel (12%) was stained with colloidal Coomassie G-250 to
visualize the amount of p53 substrate present in the kinase reaction.
Gels were dried onto a Whatmann 3 MM filter paper and exposed to an
x-ray film (Fuji Photo Film Co., Ltd.) with an intensifying screen at
80 °C. Radioactivity was quantitated by excising ATM and p53 bands
from the gel and counting the incorporated 32P by liquid scintillation
counting.
Activation and Inhibition of Kinase Activities—To prephosphorylate
ATM prior to kinase reaction, washed protein G-bound ATM immuno-
complexes were incubated with 1 mM ATP (or concentrations as indi-
cated in the figure legends) in the following phosphorylation buffer: 20
mM Tris-HCl (pH 7.5), 20 mM MgCl2, 10 mM MnCl2, 20 mM -glycero-
phosphate, 1 mM Na3VO4, 20 M microcystin. Reactions were incubated
for 30 min at 30 °C, washed three times in ice cold basic kinase buffer
to remove the ATP, and then directly used in kinase assays as described
above. Treatment of ATM immunocomplexes with ADP, AMP, NADP,
AMP-PNP, GTP, dNTPs, and polyADP ribose was performed as out-
lined for ATP. Wortmannin was dissolved in Me2SO to make a 20 mM
solution, which was stored in aliquots at80 °C. Wortmannin was used
at 1 M concentration in the reaction conditions described above. Caf-
feine was prepared fresh as a 100 mM solution in water. ATM immu-
nocomplexes were incubated on ice with a range of concentrations of
caffeine as indicated in phosphorylation buffer for 15 min and then
subjected to the reaction conditions described above.
Phosphatase Treatment of Immune Complexes—Protein G-bound
ATM immunocomplexes were additionally washed twice with basic
phosphatase buffer (50 mM Tris-HCl, pH 7.5, 5 mM dithiothreitol, 2 mM
MnCl2) and then incubated with 100 units of -protein phosphatase
(New England Biolabs) for 30 min at 30 °C. The reaction was stopped by
addition of ice-cold basic kinase buffer containing 10 mM Na3VoO4 and
10 mM NaF. Phosphatase-treated immune complexes were washed
twice with basic kinase buffer and used in kinase assays as described
above.
Tryptic Phosphopeptide Mapping—Protein G-bound ATM-immuno-
complexes from unirradiated, irradiated, and ATP-treated samples
were subjected to the autophosphorylation reaction conditions de-
scribed above. 32P-labeled ATM was separated by 5% SDS-PAGE and
visualized by autoradiography. The ATM band was excised and sub-
jected to in-gel digestion using trypsin (sequencing grade, Promega).
Peptides were extracted, and two-dimensional phosphopeptide map-
ping on thin-layer cellulose plates was performed as described (47)
using electrophoresis at pH 1.9 in the first dimension followed by
chromatography in buffer containing n-butanol/pyridine/acetic acid/wa-
ter (15:10:3:12). Plates were exposed to x-ray film with an intensifying
screen at 70 °C to detect phosphopeptides.
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RESULTS
ATM Undergoes Autophosphorylation Post-irradiation—We
initially determined whether ATM undergoes autophosphoryl-
ation in response to ionizing radiation using immunoprecipita-
tion with anti-ATM antibody. Autophosphorylation of ATM
was observed by 5 min after irradiation, and this did not
appear to increase further up to 15 min after irradiation (Fig.
1A). Indeed, no increase in autophosphorylation was observed
up to 1 h after irradiation (results not shown). On average, the
extent of this increase was 2-fold as determined by scintillation
counting of the ATM bands. As expected, ATM kinase activity
toward p531–44 substrate increased in parallel, with time (Fig.
1B). No change in the amount of ATM protein occurred under
these conditions. These data, together with previous results
showing that ATM is a phosphoprotein (41), would predict that
phosphatase treatment would abolish ATM kinase activity.
The results in Fig. 1C demonstrate that when ATM is immu-
noprecipitated from irradiated cell extracts and subsequently
treated with phosphatase, most of its kinase activity is lost
(lanes 3 and 4). This is not an artifact due to residual phospha-
tase since addition of 32P-labeled p53 to this incubation did not
result in any release of free 32P (results not shown). We also
observed a decrease in the capacity of ATM to autophosphoryl-
ate after pretreatment with phosphatase (Fig. 1D). Thus it
appears that phosphorylation status of ATM is critical to its
kinase activity.
ATP Activates ATM Kinase—Previous data have revealed
that when inactive forms of various protein kinases are incu-
bated with unlabelled ATP, they became activated by mecha-
nisms involving autophosphorylation (48–50). Since we have
shown in Fig. 1 that autophosphorylation appears to be impor-
tant for ATM activation, we rationalized that ATM protein,
immunoprecipitated from unirradiated cell extracts, had the
potential to be activated by significantly higher concentrations
of ATP than those utilized to measure ATM kinase under
standard conditions. Immunoprecipitated ATM protein from
unirradiated extracts was incubated with unlabelled ATP (1
FIG. 1. Radiation-induced activation of ATM. A, radiation-in-
duced increase in ATM autophosphorylation in vitro. ATM was immu-
noprecipitated from unirradiated and irradiated (5- and 15-min incu-
bation) control C3ABR cells, and autophosphorylation was determined
by incubation with 10 Ci of [-32P]ATP, separation on 5% SDS-PAGE
followed by transfer onto a nitrocellulose membrane, and autoradiog-
raphy. The same membrane was immunoblotted with an anti-ATM
antibody to determine ATM loading. IR, 10 Gy of ionizing radiation. IP,
immunoprecipitate. ATM-AutoP, autoradiogram of radioactive phos-
phate incorporated into ATM. ATM, Western blot of the amount of ATM
protein in the autophosphorylation reaction. 32P-p531–44-GST, autora-
diogram of radioactive phosphate incorporated into the substrate pep-
tide. p531–44-GST, Coomassie-stained gel indicating the amount of sub-
strate in the reaction. B, radiation-induced increase in ATM kinase
activity in vitro. Immunoprecipitated ATM was used in a standard
kinase reaction in the presence of 10 Ci of [-32P]ATP using GST-
p531–44 as substrate. ATM, Western blot of the amount of ATM protein
in the kinase reaction. As shown in C, phosphatase treatment abrogates
ATM kinase activity in vitro. Immunoprecipitated ATM was incubated
in phosphatase buffer or phosphatase buffer containing 100 units of
-phosphatase for 30 min at 30 °C. After subsequent removal and
inactivation of phosphatase by extensive washing with kinase buffer
containing phosphatase inhibitors, ATM was subjected to a standard
kinase reaction in the presence of 10 Ci of [-32P]ATP using GST-
p531–44 as substrate. As shown in D, phosphatase treatment affects
ATM autophosphorylation in vitro. Immunoprecipitated ATM was in-
FIG. 2. Preincubation of ATM from C3ABR cells with ATP
causes a marked increase in ATM kinase activity in vitro. Im-
munoprecipitated ATM was activated by incubation for 30 min at 30 °C
in kinase buffer with and without 1 mM unlabelled ATP. After removal
of ATP by extensive washing with kinase buffer, ATM was subjected to
a standard kinase reaction using GST-p531–44 as substrate. IP, immu-
noprecipitate. 32P-p531–44-GST, autoradiogram of radioactive labeled
substrate. ATM, Western blot of the amount of ATM protein in the
kinase reaction. p531–44-GST, Coomassie-stained substrate in the
reaction.
cubated in phosphatase buffer or phosphatase buffer containing 100
units of -phosphatase for 30 min at 30 °C. After subsequent removal
and inactivation of phosphatase by extensive washing with kinase
buffer containing phosphatase inhibitors, ATM was subjected to auto-
phosphorylation reaction in the presence of 10 Ci of [-32P]ATP.
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mM) for 30 min at 30 °C followed by washing out excess ATP
and carrying out ATM kinase activity by standard assay. Un-
der these conditions, we observed a dramatic increase in ATM
kinase activity after preincubation with unlabelled ATP
(Fig. 2).
The amount of ATM kinase activity exceeded that observed
with ATM from irradiated extracts, 10-fold as compared with
2-fold (Fig. 2, lanes 2 and 3). A further increase in kinase
activity was also observed where ATM from irradiated extracts
was preincubated with unlabelled ATP, and the overall extent
of activation was approximately the same in both cases (Fig. 2,
lanes 2 and 4). These results suggest that after irradiation, only
a proportion of ATM protein is activated, but in the presence of
excess ATP in vitro, all of the molecules are activated.
Activation Is ATM-specific—It is well established that in
vitro ATM kinase activity has a requirement for Mn2 (15, 16)
and that low concentrations of the PI3-kinase inhibitor wort-
mannin inhibit ATM kinase (45). The results in Fig. 3A show
that preincubation with ATP activates ATM kinase from unir-
radiated cell extracts in the presence of MnCl2, but in its
absence, no activation is observed.
Additional activation of ATM from irradiated extracts was
seen with ATP, and again, this was Mn2-dependent (Fig. 3B).
Wortmannin, when included in the preincubation step with
ATP, completely abolished activity (Fig. 3C). No activation was
obtained when ATP was incubated with immunoprecipitates
from an A-T cell line expressing mutant protein (Fig. 3D, lanes
3 and 4). This A-T cell line has an in-frame 9-nucleotide dele-
tion (7636del9) upstream from the kinase domain of ATM and
expresses a less stable mutant form of ATM (middle panel). A
second A-T cell line, L3, homozygous for a truncating mutation
at nucleotide 103 and not producing ATM protein, also failed to
show a response to ATP (Fig. 3D, lanes 7 and 8), supporting
specificity for ATM in this activation. To define in more detail
the dependence for ATP in ATM activation, we carried out ATP
concentration and time course experiments. The results in Fig.
4A demonstrate that ATP concentrations of 50 M and above
activate ATM kinase after a 30-min preincubation. Activation
was evident after a 5-min preincubation with 1 mM ATP, reach-
ing a maximum by 30 min (Fig. 4B). Comparison is made with
the effect of radiation (lanes 1 and 2)
Preincubation with ATP for 30 min followed by an increasing
time of incubation in [32P[ATP led to a gradual increase in p53
substrate phosphorylation (Fig. 4C). To determine whether
ATM activation required ATP hydrolysis, immunoprecipitated
ATM was preincubated with a non-hydrolyzable ATP analogue,
AMP-PNP. In contrast to preincubation with ATP, AMP-PNP
failed to activate ATM kinase toward p53 substrate (Fig. 5,
lane 4). Substitution of ATP with GTP in the preincubation
reaction did not cause any significant change in the level of
ATM kinase activity (data not shown). Only ADP, dATP, and
TTP had any appreciable effect on activity, and these were
considerably less effective than ATP (Fig. 5). Addition of soni-
cated DNA to the preincubation step or to the incubation mix
did not alter the kinase activity (results not shown). In addi-
tion, DNase treatment of the ATM immunoprecipitates did not
prevent ATP activation of ATM (results not shown).
ATM Is Activated by Autophosphorylation in Vitro—To fur-
FIG. 3. Specific activation of ATM kinase by ATP from C3ABR
cells. As shown in A, ATM kinase activation by ATP from unirradiated
extracts is Mn2-dependent. Immunoprecipitated ATM was activated
by incubation for 30 min at 30 °C in kinase buffer containing 1 mM
unlabelled ATP in the presence or absence of Mn2. After removal of
ATP by extensive washing with kinase buffer, ATM was subjected to a
standard kinase reaction using GST-p531–44 as substrate. IP, immuno-
precipitate. 32P-p531–44-GST, autoradiogram of radioactive labeled sub-
strate. p531–44-GST, Coomassie-stained substrate in the reaction. As
shown in B, ATM kinase activation by ATP in irradiated cell extracts is
Mn2-dependent. ATM immunoprecipitated from cell extracts prepared
form irradiated cells was activated by incubation for 30 min at 30 °C in
kinase buffer containing 1 mM unlabelled ATP in the presence or
absence of Mn2. After removal of ATP by extensive washing with
kinase buffer, ATM was subjected to a standard kinase reaction using
GST-p531–44 as substrate. IR, 10 Gy of ionizing radiation. ATM, West-
ern blot of the amount of ATM protein in the kinase reaction. As shown
in C, ATM kinase activation by ATP is inhibited by wortmannin. Im-
munoprecipitated ATM was incubated for 30 min at 30 °C in kinase
buffer or kinase buffer containing 1 M wortmannin and/or 1 mM ATP.
After washing with kinase buffer, ATM was subjected to a normal
kinase reaction using GST-p531–44 as substrate. As shown in D, ATM
kinase activation by ATP is absent in A-T cell lines. Cell extracts were
prepared from control (C3ABR) and two A-T cell lines, L3 not express-
ing ATM protein and AT1ABR expressing near full-length mutated
ATM. Immunoprecipitates were activated by incubation for 30 min at
30 °C in kinase buffer containing 1 mM unlabelled ATP. After removal
of ATP by extensive washing with kinase buffer, ATM was subjected to
a standard kinase reaction using GST-p531–44 as substrate.
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ther confirm that autophosphorylation is an inherent part of
ATM activation, we carried out successive treatments with
ATP and phosphatase with immunoprecipitated ATM from
irradiated and unirradiated extracts. As observed above, ATP
activated ATM kinase from unirradiated extracts, and subse-
quent phosphatase treatment abolished this capacity for acti-
vation (Fig. 6A, lanes 3 and 4). However, it was possible to
restore activity after phosphatase treatment and washing
away excess phosphatase by incubating again with ATP prior
to carrying out the kinase assay (Fig. 6A, lane 5). This was also
the case for immunoprecipitates from irradiated extracts (Fig.
6A, right panel). Increasing ATP concentrations over the range
0–2 mM failed to show a change in ATM autophosphorylation
either for irradiated or for unirradiated immunoprecipitates
(Fig. 6B). This can be explained by having different levels of
activation of ATM at different ATP concentrations. In the less
activated case, at lower ATP preincubation concentrations,
more sites would be available for 32P incorporation in the
subsequent autophosphorylation, whereas at higher ATP con-
centrations, fewer sites would be unphosphorylated, but the
enzyme would have more activity. The end result would repre-
sent little change in incorporation at the different ATP concen-
trations. To demonstrate that autophosphorylation was indeed
part of the mechanism of activation, we carried out tryptic
phosphopeptide mapping. For ATM from irradiated cells, at
least seven phosphopeptides (circled) were evident after tryptic
digestion, indicating that there are multiple phosphorylation
sites on ATM (Fig. 6C). It is clear that when ATM kinase is
activated by ATP, substantial overlap occurs between the two
phosphorylation patterns (Fig. 6C). Notably absent in the ATP
activated sample are phosphopeptides 3 and 7. It should be
noted that ATM isolated from unirradiated cells has low basal
activity, and this is reflected in appearance of some of these
phosphopeptides. In essence, these data reveal that autophos-
phorylation appears to be essential for ATM kinase activity at
least in vitro.
Previous results reveal that preincubation of cells with caf-
feine, a compound that overrides cell cycle checkpoints and
radiosensitizes cells by inhibiting both ATM and ATR, did not
affect radiation-induced ATM kinase when subsequently as-
sayed in vitro (44). These data were interpreted to mean that
the pathway leading to ATM activation in irradiated cells is
insensitive to caffeine and that this activation does not involve
autophosphorylation. These results appear to be at odds with
the ATP-induced autophosphorylation of ATM observed here.
To address this, we preincubated ATM immunoprecipitates
from unirradiated cells with caffeine, prior to incubation with
unlabelled ATP and subsequent washing out before measuring
kinase activity. When caffeine (1 mM) was added with unla-
belled ATP in the preincubation step to immunoprecipitates, it
failed to interfere with activation of ATM (Fig. 7A). A small
stimulation of activity was observed with caffeine alone. How-
ever, when caffeine was added to the kinase reaction with p53
substrate, as expected, it inhibited substrate phosphorylation
by ATM (Fig. 7B). Caffeine concentrations up to 4 mM failed to
interfere with in vitro activation (results not shown). It is
evident from the results in Fig. 7C that preincubation of cells
with caffeine did not interfere with the activation of ATM
kinase, as observed by Sarkaria et al. (44). Again caffeine on its
own had some stimulatory activity. Incubation of ATM immu-
noprecipitates with 1 mM caffeine in the kinase reaction had
only a minimal effect on autophosphorylation (results not
shown). These data suggest that although caffeine inhibits
ATM kinase activity, it fails to interfere with autophosphoryl-
ation of ATM, thus distinguishing between the two types of
activity.
Since small molecules have also been shown to alter the
autophosphorylation capacity and activity of other PI3-kinase
family members (35, 36, 38, 39) we determined whether ATP
activation might extend to DNA-PK and ATR in vitro. Incuba-
tion of ATP with immunoprecipitates of DNA-PK and ATP
failed to significantly activate these kinases (Fig. 8, A and B),
indicating that this was not some nonspecific effect capable of
stimulating other family members because they possessed a
protein kinase domain and an ATP-binding region.
FIG. 4. Concentration and time-dependent ATM activation by
ATP. A, effect of ATP concentration on activation. Immunoprecipitated
ATM was incubated for 30 min at 30 °C in kinase buffer containing
different concentrations of unlabelled ATP as indicated. After removal
of ATP by extensive washing with kinase buffer, ATM was subjected to
a standard kinase reaction using GST-p531–44 as substrate. IP, immu-
noprecipitate. ATM, Western blot of the amount of ATM protein in the
autophosphorylation reaction. 32P-p531–44-GST, autoradiogram of ra-
dioactive phosphate incorporated into the substrate peptide. p531–44-
GST, Coomassie-stained gel indicating the amount of substrate in the
reaction. B, time course of ATP preincubation for activation. Immuno-
precipitated ATM was incubated for different time intervals as indi-
cated at 30 °C in kinase buffer containing 1 mM unlabelled ATP. After
removal of ATP by extensive washing with kinase buffer, ATM was
subjected to a standard kinase reaction using GST-p531–44 as substrate.
Lanes 1 and 2 depict ATM kinase activity in immunoprecipitates from
unirradiated or irradiated samples without ATP preincubation condi-
tions. IR, 10 Gy of ionizing radiation. As shown in C, immunoprecipi-
tated ATM was activated by incubation for 30 min at 30 °C in kinase
buffer containing 1 mM unlabelled ATP. After removal of ATP by ex-
tensive washing with kinase buffer, ATM was subjected to a standard
kinase reaction for various time intervals as indicated using GST-
p531–44 as substrate.
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DISCUSSION
The data described here provide good evidence that ATM can
be activated in vitro by an autophosphorylation mechanism to
phosphorylate downstream substrates such as p53. When im-
munoprecipitated from unirradiated cell extracts, ATM has a
low basal level of kinase activity that is markedly enhanced by
prior incubation with unlabelled ATP. The extent of ATM ac-
tivation exceeds that observed in irradiated samples, suggest-
ing that ATP is titrating out all the ATM activity. Further
enhancement of ATM activation by ATP in immunoprecipitates
from irradiated cells by ATP supports this. Previous data re-
veal that ATM is only activated 2- to 3-fold above the basal
level by exposure to radiation doses as high as 10 Gy (15, 16, 21,
24, 25). These results suggest that not all of the ATM is acti-
vated in vivo by radiation. Although it is not clear how ATM is
activated in irradiated cells, it appears to be due to recognition
of double strand breaks in DNA either by direct binding
through a complex with other proteins such as the Brca1-
associated genome surveillance complex (BASC) complex (51)
or perhaps by responding to changes in the superhelicity of
chromatin remote from the actual site of the break. The acti-
vation of only some of the ATM protein after irradiation is
consistent with recent data demonstrating heterogeneous dis-
tribution of ATM within the nucleus (52). A subset of the ATM
pool appears to rapidly associate with chromatin and the nu-
clear matrix at sites of double strand breaks (52). Most of the
ATM is loosely tethered to the nucleus; however, both fractions
contain at least some active ATM kinase.
It is evident from our data that activation of ATM from
unirradiated cells is only observed at concentrations of ATP
from 0.05 mM up to physiological concentrations. Under kinase
reaction conditions, the concentration of ATP is 5–10 M, which
clearly distinguishes between immunoprecipitates from irradi-
ated and unirradiated cells (15, 16). The difference between
irradiated and unirradiated could be due to greater access of
ATP to the kinase active site in the former case. Radiation
damage to DNA could alter the conformation of ATM or its
association with an interacting protein to provide unrestricted
access to the active site. This phenomenon has been observed
with TAK1, a member of the mitogen-activated kinase kinase
kinase family, which is activated in vivo by different cytokines
(53). When phosphatase-treated immunoprecipitates of TAK1
are subsequently incubated with cold ATP (1 mM) and reas-
sayed, kinase activity is greatly increased (54). How do we
explain activation by higher concentrations of ATP? Activation
could simply be due to an excess of a charged molecule, which
caused a switch from basal to active states. This seems unlikely
since a variety of nucleotide analogs failed to appreciably raise
activity, and poly ADP-ribose also failed to activate ATM (re-
FIG. 5. Activation of ATM by ATP analogues and other nucle-
otides. Immunoprecipitated ATM was incubated for 30 min at 30 °C in
kinase buffer containing ATP or other nucleotides as indicated. After
removal of ATP by extensive washing with kinase buffer, ATM was
subjected to a standard kinase reaction using GST-p531–44 as substrate.
32P-p531–44-GST, autoradiogram of radioactive phosphate incorporated
into the substrate peptide. ATM, Western blot of the amount of ATM
protein in the kinase reaction. p531–44-GST, Coomassie stained gel
indicating the amount of substrate in the reaction.
FIG. 6. ATM is activated by autophosphorylation. A, effect of
successive phosphorylation and dephosphorylation on ATM kinase ac-
tivity. Immunoprecipitated ATM was incubated for 30 min at 30 °C in
kinase buffer or kinase buffer containing 1 mM ATP. After removal of
ATP by extensive washing with kinase buffer, ATM was incubated in
phosphatase buffer or phosphatase buffer containing 100 units of
-phosphatase for 30 min at 30 °C. After subsequent removal of phos-
phatase by extensive washing with kinase buffer, ATM was again
incubated in kinase buffer or kinase buffer containing 1 mM ATP for 30
min at 30 °C. After additional washing with kinase buffer, ATM was
subjected to a normal kinase reaction using GST-p531–44 as substrate.
Left panel, immunoprecipitates (IP) from unirradiated extracts (lanes
3–5). Right panel, immunoprecipitates from irradiated extracts (lanes
8–10). IR, 5 Gy of ionizing radiation. ATP (1), first round of incubation
with ATP. ATP (2), second round of incubation with ATP. 32P-p531–44-
GST, autoradiogram of radioactive phosphate incorporated into the
substrate peptide. ATM, Western blot of the amount of ATM protein in
the kinase reaction. p531–44-GST, Coomassie-stained gel indicating the
amount of substrate in the reaction. ATM-AutoP, autoradiogram of
radioactive phosphate incorporated into ATM. B, effect of pretreatment
with ATP on ATM autophosphorylation. Immunoprecipitated ATM was
incubated for 30 min at 30 °C in kinase buffer or kinase buffer contain-
ing ATP. After removal of ATP by extensive washing with kinase buffer,
ATM was subjected to autophosphorylation reaction in the presence of
10 Ci of [-32P]ATP. Lane 1 depicts ATM autophosphorylation in
immunoprecipitates from irradiated (two upper lanes) or unirradiated
(two lower lanes) samples without ATP preincubation conditions. Ig
ATM, immunoprecipitated and stained ATM. C, tryptic phosphopeptide
mapping of ATM, autophosphorylated in vitro from unirradiated (UN-
IRR), irradiated, and ATP-activated ATM. Immunoprecipitates were
subjected to ATM autophosphorylation conditions as described under
“Experimental Procedures” followed by 5% SDS-PAGE. The labeled
ATM protein band was enzymatically digested with trypsin. The result-
ing peptides were separated in the first and second dimension by
electrophoresis and chromatography, respectively. The origins are
marked by diamonds, and the positions of the phosphopeptides are
indicated by circles.
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sults not shown). More likely, the Km for ATP binding to the
unirradiated ATM is considerably higher than that for irradi-
ated, possibly as a consequence of the ATP/substrate-binding
site being occluded by an inhibitory domain of ATM itself or
due to interaction with another protein. This may be related to
the behavior of ATM during purification where it binds tightly
to -phosphate-linked ATP-Sepharose, but it is readily eluted
from a metal-chelating Sepharose resin as a constitutively ac-
tive phosphoprotein (45).
We have demonstrated here that autophosphorylation is a
key event in the activation of ATM kinase in vitro and that the
pattern of autophosphorylation induced by ATP bears consid-
erable overlap with that seen in radiation-activated ATM. It
appears that multiple autophosphorylation sites exist on ATM
after both treatments. Treatment of ATP-activated ATM ki-
nase with phosphatase abrogated activity, but this was fully
restored upon subsequent incubation with ATP. Evidence for
ATM autophosphorylation has been observed previously, but
its importance was not highlighted (23, 25). In one of these
reports, a radiation-induced increase in ATM phosphorylation
in controls was not observed in an A-T cell line (25).
[32P]orthophosphate labeling in vivo provides evidence for
ATM autophosphorylation in response to radiation damage
supported by a failure to observe this effect in cells expressing
kinase-dead ATM (23). The activation observed here was spe-
cific for ATM since it was absent in immunoprecipitates from
A-T patients expressing mutant protein, was dependent on the
presence of Mn2, and was inhibited by wortmannin. These
data suggest that at least in vitro, no other kinase is required
for the activation of ATM, and this may also be the case in
irradiated cells. These observations appear to be contradictory
to those of Sarkaria et al. (44), who reported that preincubation
of cells with caffeine prior to radiation exposure failed to pre-
vent the radiation-induced activation of ATM, as measured in
immunoprecipitates, but prevented radiation-induced phos-
phorylation of p53 in the cell. They interpreted these results to
mean that autophosphorylation was not part of the mechanism
for ATM activation. We made the same observations as
Sarkaria et al. (44) with pretreatment of cells with caffeine, but
we described a differential effect of caffeine on autophospho-
rylation and its capacity to phosphorylate added substrate.
Caffeine did not interfere with ATP-dependent activation of
ATM kinase (i.e. autophosphorylation) at concentrations up to
4 mM, but it did prevent substrate phosphorylation when in-
cluded in the kinase reaction. Thus the data are not contradic-
tory but rather demonstrate that autophosphorylation of ATM,
whether it be induced in vivo by radiation or in vitro by ATP, is
not inhibited by caffeine, but the capacity of ATM to phospho-
rylate substrates such as p53 in vivo or in vitro is prevented by
FIG. 7. Effect of caffeine pretreatment on ATM kinase activity.
As shown in A, immunoprecipitated ATM was incubated for 30 min at
30 °C in kinase buffer or kinase buffer containing 1 mM caffeine and/or
1 mM ATP. After washing with kinase buffer, ATM was subjected to a
standard kinase reaction using GST-p531–44 as substrate. IP, immuno-
precipitate. 32P-p531–44-GST, autoradiogram of radioactive labeled sub-
strate. ATM, Western blot of the amount of ATM protein the kinase
reaction. p531–44-GST, Coomassie-stained substrate in the reaction. B,
effect of caffeine in the kinase reaction. Immunoprecipitated ATM was
incubated for 30 min at 30 °C in kinase buffer or kinase buffer contain-
ing 1 mM ATP. After washing with kinase buffer to remove the ATP,
ATM was subjected to a kinase reaction in the presence of 1 mM
caffeine, 10 Ci of [-32P]ATP and GST-p531–44 as substrate. C, ATM
kinase activity after treatment of cells with caffeine. Control (C3ABR)
cells were treated with 3 mM caffeine for 1 h before irradiation. ATM
was subsequently immunoprecipitated and subjected to a standard
kinase assay using GST-p531–44 as substrate. IR, 5 Gy of ionizing
radiation.
FIG. 8. Effect of ATP on activation of other PI3-kinases. Effect
of ATP pretreatment on ATR and DNA-PKcs kinase activity. Immuno-
precipitated ATR (A) and DNA-PKcs (B) were subjected to ATP pre-
treatment (0–2 mM as described above) before kinase activity was
determined by standard kinase reaction in the presence of 10 Ci of
[-32P]ATP using GST-p531–44 as substrate. The amount of kinase in
the reaction was determined by Western blot against ATR or DNA-PK,
respectively. The specificity of the immunoprecipitation was verified by
using nonspecific antiserum (lane ns). IP, immunoprecipitate. 32P-
p531–44-GST, autoradiogram of radioactive labeled substrate. DNA-
PKcs, Western blot of the amount of DNA-PKcs protein in the kinase
reaction. ATR, Western blot of the amount of ATR protein in the kinase
reaction. p531–44-GST, Coomassie-stained substrate in the reaction.
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caffeine. Although caffeine has been shown to interfere with
cell cycle checkpoints and radiosensitize cells, the exact mech-
anism of action remains unknown. This compound inhibits
both ATM and ATR kinase activities (44, 55), but it is not clear
whether this purine analog competes with ATP or inhibits the
enzymes by some other mechanism. The differential effect of
caffeine on ATM autophosphorylation and substrate phospho-
rylation suggests that it is not simply competition with ATP for
active site binding that causes inhibition. In this context, it is
of considerable interest that several of the ATM substrates
including p53, BRCA1, and BLM not only bind to the kinase
domain in vitro but also bind to a region close to the N terminus
of the protein (17, 25, 27). In addition, p53 and BRCA1 have
been shown by co-immunoprecipitation to bind constitutively to
ATM (17, 56). Thus, although two sites may be required for
substrate phosphorylation, this would not be expected in the
case of autophosphorylation and could explain differential in-
hibitory effects as observed here for caffeine. A greater under-
standing of the mechanism of ATM autophosphorylation will
allow for the identification of more specific inhibitors than
caffeine. Preincubation of cells with wortmannin, an inhibitor
of ATM kinase, suggested that autophosphorylation is not re-
quired for the nuclear retention of ATM kinase (52). However,
it should be pointed out that in that report, the bulk of ATM
kinase was not tightly bound to chromatin but was neverthe-
less activated by radiation.
It is well established that serine/threonine protein kinases
are activated due to conformational change in the molecule as
a consequence of binding to a variety of ligands or by phospho-
rylation by upstream kinases (57). This alters the conformation
of the protein, allowing increased access to ATP and substrate.
In the present case, it is conceivable that a substrate such as
p53 (e.g. as a tetramer), which is capable of binding to the two
ends of the ATM molecule simultaneously, would effectively
close off the active site by excluding access to ATP and main-
taining the kinase in an inactive state. In the case of immuno-
precipitates, removal of ATM and its associated proteins from
their nuclear location may be sufficient to alter the conforma-
tion to an extent at which access to ATP occurs at higher
concentrations. An alternative possibility for activation is that
ATP binds at another site on ATM or on an associated protein
and alters its conformation to allow more favorable access to
the ATP-binding site within the active site. Previous data have
demonstrated that ATP molecules bind co-operatively to the
Escherichia coli chaperonin GroEL and cause long range con-
formational changes that determine the orientations of remote
substrate-binding sites (58). ATP has also been shown to in-
duce an increase in Ca 2-dependent K channel (hIK1) activ-
ity, whereas several of its hydrolysable or non-hydrolysable
analogs failed to do so (59). Another member of the P13-kinase
family, mTOR, plays an important role in ribosome biogenesis
and cell growth (36). Recent data demonstrate that the intra-
cellular concentration of ATP alters the activity of mTOR in-
dependent of amino acid-induced changes (36). As ATP in-
creases up to 1 mM, the activity of mTOR, detected as S6K1
activation, increased. These data were interpreted to mean
that mTOR is a direct sensor of ATP in the cell. It is also of
interest that mTOR bound to ATP agarose is efficiently eluted
off the matrix with excess cold ATP (60). Phosphatidic acid also
interacts with mTOR, which is positively correlated with the
ability of mTOR to activate downstream substrates (61). An-
other small molecule inositol hexakisphosphate has been
shown to stimulate the kinase activity of DNA-PK by interact-
ing specifically with the Ku7u/80 heterodimer (35).
In summary, we have shown that ATP activates ATM kinase
in vitro by a mechanism involving autophosphorylation. The
process of autophosphorylation is resistant to caffeine inhibi-
tion, whereas substrate phosphorylation is sensitive to this
agent. Activation is specific for ATM and is not observed to a
significant extent with either ATR or DNA-PK. This is in agree-
ment with previous results employing purified DNA-PK in
which preincubation with unlabelled ATP in the absence of
DNA failed to appreciably alter the activity (62). When DNA
was included in the preincubation, autophosphorylation of
DNA-PKcs reduced its capacity to phosphorylate exogenous
substrates (38). It is intriguing that autophosphorylation has
the opposite effect on the activities of these two P13-kinase
family members that recognize double strand breaks in DNA.
It is proposed that a similar mechanism for activation occurs in
the cell, where DNA double strand breaks either indirectly
alter the conformation of ATM or indirectly alter its association
with an interacting protein, allowing unrestricted access to
ATP for autophosphorylation and substrate phosphorylation.
Clearly, it is important to determine how the observations
made here impact upon in vivo activation of ATM kinase.
Identification of the in vivo phosphorylation sites on ATM are
critical to an overall understanding of the mechanism of
activation.
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